Fabentech
PrivateLast Round
Debt
Oct 7, 2024
Total Funding Raised
$15.65M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Fabentech operates in Healthcare & Life Sciences and is based in Lyon. Its latest recorded funding round was a Grant round in December 2021.
Fabentech is a biopharmaceutical company that develops and produces polyclonal antibody-based immunotherapies to address high-priority biological threats and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Defense Tech, Drug Discovery
Business Model
B2G
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fabentech Comparables
Compare Fabentech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PlantForm Corporation | 78% | |
| SAb Biotherapeutics | 76% | |
| Emergent Biosolutions Inc. | 73% |
For institutional investors. Book with your work email.
Fabentech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Oct 7, 2024 | ||||
| Grant | Dec 9, 2021 | ||||
| VC Round | Jan 31, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Fabentech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Elaia Partners | VC Round |
| Entrepreneur Invest | VC Round |
| European Commission | Grant |
| Kreaxi | VC Round |
| European Investment Bank Group | Debt |
| Bpifrance | VC Round |
| Institut Mérieux | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 174% MoM.
- Oct 7, 2024
$22M round led by European Investment Bank Group
For institutional investors. Book with your work email.
Fabentech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Fabentech's valuation, stock price, and market status.
Is Fabentech a public or private company?
Fabentech is a private company.
What is the current stock price of Fabentech?
Fabentech is a private company, so its shares have no public market price. Caplight tracks Fabentech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Fabentech worth (valuation)?
Valuation information for Fabentech is not publicly available.
Can I buy Fabentech stock?
Fabentech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Fabentech's last funding round?
Fabentech's most recent funding round was Debt on October 7, 2024.
Who are the main investors in Fabentech?
Key investors in Fabentech include European Investment Bank Group.
Will Fabentech IPO soon?
No public IPO plans have been announced for Fabentech.
How can I track Fabentech secondary market activity?
Caplight tracks bids, offers, and trades in Fabentech's shares on secondary markets.